Cargando…

Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study

BACKGROUND: Metabolic syndrome (MetS) increases risk of cardiovascular diseases (CVD), premature death as well as cost related to health care.This study was aimed at investigating the prevalence of MetS and its determinant factors among type2 diabetes mellitus (T2DM) patients attending a specialized...

Descripción completa

Detalles Bibliográficos
Autores principales: Birarra, Mequanent Kassa, Gelayee, Dessalegn Asmelashe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050670/
https://www.ncbi.nlm.nih.gov/pubmed/30016936
http://dx.doi.org/10.1186/s12872-018-0880-7
_version_ 1783340385485979648
author Birarra, Mequanent Kassa
Gelayee, Dessalegn Asmelashe
author_facet Birarra, Mequanent Kassa
Gelayee, Dessalegn Asmelashe
author_sort Birarra, Mequanent Kassa
collection PubMed
description BACKGROUND: Metabolic syndrome (MetS) increases risk of cardiovascular diseases (CVD), premature death as well as cost related to health care.This study was aimed at investigating the prevalence of MetS and its determinant factors among type2 diabetes mellitus (T2DM) patients attending a specialized hospital. METHODS: A cross-sectional study was conducted on a total of 256 T2DM patients from the first march to 30th May 2017 at university of gondar comprehensive specialized hospital (UGCSH). Data was collected based on STROBE (strengthening the reporting of observational studies in epidemiology) statement. Bivariable and multivariable logistic regression analysis were run to identify predictors of MetS from the independent variables and significance test was set at P <  0.05. RESULTS: The prevalence of MetS in this study was 70.3, 57 & 45.3% and it is more common in females (66.1, 83.3 & 70.7%) by using national cholesterol education program adult treatment panel III (NCEP-ATP III), International diabetic federation (IDF) and world health organization (WHO) criteria respectively. The most prevalent components of MetS were low level of high density lipoprotein (HDL) and triglyceride(TG). By usingIDF criteria, female gender was significantly associated with MetS (AOR = 0.2 at 95%CI: 0.1, 0.6 P = 0.00). Where as by NCEP-ATP IIIcriteria, age between 51 and 64 years old (AOR = 2.4 95% CI: 1.0,5.8, P = 0.04), self employment (AOR = 2.7 95% CI:1.1, 6.5, P = 0.03), and completetion of secondary school and above (AOR = 3.2, 95% CI:1.6,6.7, P = 0.001) were predictors for the development of MetS. In the WHO criteria, being single in marital status was significantly associated with MetS (AOR = 17 at 95%CI: 1.8, 166, P = 0.000). CONCLUSIONS: This study demonstrates that Metabolic syndrome is a major health concern for diabetic patients in Ethiopia and they are at increased risk of developing complications such as cardiovascular diseases and premature mortality. The predictors female gender, age between 51 and 64 years old, urban area residence, and being single are modifiable.Thus,health authorities shall provide targeted interventions such as life style modifications to these most at risk sub-populations of diabetic patients.
format Online
Article
Text
id pubmed-6050670
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60506702018-07-19 Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study Birarra, Mequanent Kassa Gelayee, Dessalegn Asmelashe BMC Cardiovasc Disord Research Article BACKGROUND: Metabolic syndrome (MetS) increases risk of cardiovascular diseases (CVD), premature death as well as cost related to health care.This study was aimed at investigating the prevalence of MetS and its determinant factors among type2 diabetes mellitus (T2DM) patients attending a specialized hospital. METHODS: A cross-sectional study was conducted on a total of 256 T2DM patients from the first march to 30th May 2017 at university of gondar comprehensive specialized hospital (UGCSH). Data was collected based on STROBE (strengthening the reporting of observational studies in epidemiology) statement. Bivariable and multivariable logistic regression analysis were run to identify predictors of MetS from the independent variables and significance test was set at P <  0.05. RESULTS: The prevalence of MetS in this study was 70.3, 57 & 45.3% and it is more common in females (66.1, 83.3 & 70.7%) by using national cholesterol education program adult treatment panel III (NCEP-ATP III), International diabetic federation (IDF) and world health organization (WHO) criteria respectively. The most prevalent components of MetS were low level of high density lipoprotein (HDL) and triglyceride(TG). By usingIDF criteria, female gender was significantly associated with MetS (AOR = 0.2 at 95%CI: 0.1, 0.6 P = 0.00). Where as by NCEP-ATP IIIcriteria, age between 51 and 64 years old (AOR = 2.4 95% CI: 1.0,5.8, P = 0.04), self employment (AOR = 2.7 95% CI:1.1, 6.5, P = 0.03), and completetion of secondary school and above (AOR = 3.2, 95% CI:1.6,6.7, P = 0.001) were predictors for the development of MetS. In the WHO criteria, being single in marital status was significantly associated with MetS (AOR = 17 at 95%CI: 1.8, 166, P = 0.000). CONCLUSIONS: This study demonstrates that Metabolic syndrome is a major health concern for diabetic patients in Ethiopia and they are at increased risk of developing complications such as cardiovascular diseases and premature mortality. The predictors female gender, age between 51 and 64 years old, urban area residence, and being single are modifiable.Thus,health authorities shall provide targeted interventions such as life style modifications to these most at risk sub-populations of diabetic patients. BioMed Central 2018-07-17 /pmc/articles/PMC6050670/ /pubmed/30016936 http://dx.doi.org/10.1186/s12872-018-0880-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Birarra, Mequanent Kassa
Gelayee, Dessalegn Asmelashe
Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title_full Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title_fullStr Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title_full_unstemmed Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title_short Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
title_sort metabolic syndrome among type 2 diabetic patients in ethiopia: a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050670/
https://www.ncbi.nlm.nih.gov/pubmed/30016936
http://dx.doi.org/10.1186/s12872-018-0880-7
work_keys_str_mv AT birarramequanentkassa metabolicsyndromeamongtype2diabeticpatientsinethiopiaacrosssectionalstudy
AT gelayeedessalegnasmelashe metabolicsyndromeamongtype2diabeticpatientsinethiopiaacrosssectionalstudy